돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 10501생성일: 2026년 10월 24일

N,N,N',N'-Tetramethylazodicarboxamide → N-(tert-butoxycarbonyl)-3-[(1-chloro-5-isoquinolyl)oxy]propylamine

https://huagongshe.com/ko/reaction/10501

반응식

참여 물질

역할이름HCID투입량
반응물N,N,N',N'-TetramethylazodicarboxamideHCID 4278—
반응물TributylphosphineHCID 13831—
반응물tert-butyl N-(3-hydroxypropyl)carbamateHCID 3838134—
반응물1-Chloroisoquinolin-5-olHCID 21979933—
용매TetrahydrofuranHCID 8028—
생성물N-(tert-butoxycarbonyl)-3-[(1-chloro-5-isoquinolyl)oxy]propylamineHCID 21979957—

반응 단계

A suspension of 1-chloro-5-hydroxyisoquinoline (539 mg, synthesized according to the method described in a reference (Georgian, V. et al., J. Org. Chem., 27, 4571 (1962))), (3-hydroxypropyl)carbamic acid tert-butyl ester (1.58 g, Tokyo Kasei Kogyo) and 1,1′-azobis(N,N-dimethylformamide) (1.55 g) in tetrahydrofuran (8 ml) was added with tri(n-butyl)phosphine (2.24 ml) with ice cooling and stirred at room temperature for 24 hours. The deposited solid was removed by filtration, and the solvent was evaporated under reduced pressure. Then, the residue was purified by silica gel column chromatography (n-hexane:ethyl acetate=3:1) to obtain the title compound (860 mg) as white powdery solid.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07094789B2
출처 데이터셋uspto-grants-2006_08
ORD IDord-881ac3f56ed04e33b46fda327ae9d93f
출처 메모uspto-grants-2006_08